The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles

Released On
February 20, 2020

Expires On
February 19, 2021

Media Type
Internet

Completion Time
120 minutes

Specialty
Case Management, Education, Emergency Medicine, Hospitalist, Infectious Disease, Neurology, Occupational Medicine, Pain Management, Pharmacy, Physiatry, Primary Care, Psychiatry

 

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and Terranova Medica LLC.

 

Supported by an educational grant from EMD Serono.

Credit Available

  • Physicians — maximum of 2.0 AMA PRA Category 1 Credit(s)
  • Nurses — 2 Nursing Contact Hours
  • Pharmacists — 0.2 Contact hours (0.2 CEUs)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity has been designed to meet the educational needs of physicians, pharmacists, nursing professionals, and other members of the healthcare team involved in the management of patients with MS.

Program Overview

The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles will review the immunology of MS and its application in therapeutic selection. Using case examples, the faculty will address the disease, drug, and patient factors affecting the choice of initial and sequential therapies. Triple accredited for physicians, nurses, and pharmacists, this activity will appeal to the entire range of clinicians who care for MS patients.

Learning Objectives

Upon completing this activity, participants should be better able to:

  • Describe the current understanding of the immune-pathophysiology of MS
  • Categorize disease-modifying therapies (DMTs) in terms of immune reconstitution therapies vs maintenance regimens, with an eye toward their immunosuppressive properties
  • Analyze disease, therapeutic, and patient factors impacting the choice of initial and sequential therapy for relapsing/remitting MS
  • Tailor DMT for patients with MS based on an informed risk-benefit analysis
  • Educate patients to understand the principles of immune reconstitution therapy and adhere to the regimen

Faculty

Bruce A. Cohen, MD

Director, Northwestern Comprehensive Multiple Sclerosis Program
Professor, Davee Department of Neurology and Clinical Neurological Sciences
Northwestern University, Feinberg School of Medicine
Chicago, Illinois

Jacquelyn (Jacci) Bainbridge, BS Pharm, PharmD, FCCP, MSCS

Professor, Department of Clinical Pharmacy
University of Colorado
Anschutz Medical Campus
Skaggs School of Pharmacy, Department of Clinical Pharmacy and Neurology
Aurora, Colorado

Amy Perrin Ross, RN, MSN, CNRN, MSCN

Neuroscience Program Coordinator
Loyola University Medical Center
Maywood, Illinois

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Terranova Medica LLC. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation

Physicians: The Consortium of Multiple Sclerosis Centers (CMSC) designates this enduring activity for a maximum of 2.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nurses: The Consortium of Multiple Sclerosis Centers designates this activity for 2.0 contact hours of continuing education (2.0 in the area of pharmacology) for nurses.

Pharmacists: The Consortium of Multiple Sclerosis Centers (CMSC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education and will award 0.2 contact hours (0.2 CEUs) to pharmacists who (1) complete the activity, (2) submit a passing posttest, and (3) complete the evaluation form. The Universal Activity Number (UAN) for this activity is JA4008165-9999-20-003-H01-P. This is a knowledge-based activity.

Upon successful completion of the activity, your CE credits will be submitted electronically to the NABP CPE Monitor service.  For information about CPE Monitor, visit https://nabp.pharmacy/cpe-monitor-service/

Disclosures of Conflicts of Interest

Bruce A. Cohen, MD, has disclosed the following relevant financial relationships:

  • Consulting fees: Biogen, EMD Serono, Genentech, Mylan
  • Contracted Research Support: Genentech/Roche, MedDay

Jacquelyn Bainbridge, BS Pharm, PharmD, FCCP, MSCS, has disclosed the following relevant financial relationships:

  • Advisory Board: Genentech

Amy Perrin Ross, RN, MSN, CNRN, MSCN has disclosed the following relevant financial relationships:

  • Consulting fees: Biogen, EMD Serono, TEVA, Genzyme, Genentech, Alexion, Celgene, Novartis
  • Speakers Bureau: Biogen, EMD Serono, TEVA, Genzyme, Genentech, Alexion, Novartis

Disclosure of Unlabeled Use

CMSC and Terranova Medica LLC require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Method of Participation/How to Receive Credit

  1. Register and complete all the sections
  2. Complete all the online Posttest sections with a score of 75% or better
  3. Once you complete the Posttest, a link to the evaluation will be unlocked
  4. Upon completion of the evaluation, you will receive an immediate CME/CE Certificate to download and/or print for your files

Disclaimer

CMSC and Terranova Medica LLC present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC, Terranova Medica LLC, and the commercial supporters assume no liability for the information herein.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Privacy Policy

Terranova Medica LLC and CMSC are committed to protecting the privacy of those who choose to participate in activities on artofmstherapy.org. This information below describes our security policies for safeguarding personal information as well as the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of personal information
Terranova Medica LLC and CMSC do not transfer, sell, or share personal information with outside parties. We will not disclose the information unless required in a legal proceeding.

Contact Information

If you have any questions about this activity, please contact Tom Davis of Terranova Medica LLC by telephone/fax (877-276-4523) or email (tdavis@terranovamedica.com).